Search for a trial

A Phase 2a Open-label Study to Evaluate Prediction of Response to Golimumab Using a
Transcriptomic Profile in Subjects with Moderately to Severely Active Ulcerative Colitis

OBJECTIVES AND HYPOTHESIS Primary ObjectiveThe primary objective is to evaluate the accuracy of the length-109 probe set panel in predicting mucosal healing (ie, improvement in the endoscopic appearance of the mucosa) at Week 6, as measured by the…